Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.
暂无分享,去创建一个
L. Niskanen | S. Saarikoski | M. Parviainen | H. Kröger | M. Tuppurainen | A. Heikkinen | M. Komulainen | M. Parviainen | Anna‐Mari Heikkinen
[1] F. Singer,et al. Bone-resorption markers galactosyl hydroxylysine, pyridinium crosslinks, and hydroxyproline compared. , 1992, Clinical chemistry.
[2] J. Risteli,et al. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. , 1993, Clinical chemistry.
[3] O. Johnell,et al. Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: A retrospective and prospective population‐based study of women , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[4] P. Delmas,et al. SERUM BONE GLA-PROTEIN: A SPECIFIC MARKER FOR BONE FORMATION IN POSTMENOPAUSAL OSTEOPOROSIS , 1984, The Lancet.
[5] L. Mosekilde,et al. Assessment of bone remodeling using biochemical indicators of type I collagen synthesis and degradation: relation to calcium kinetics. , 1994, Bone and mineral.
[6] R. Hoover,et al. Oral contraceptives and endometrial cancer: Do other risk factors modify the association? , 1993, International journal of cancer.
[7] M. Nozaki,et al. The chronological change of vertebral bone loss following oophorectomy using dual energy X-ray absorptiometry: the correlation with specific markers of bone metabolism. , 1995, Maturitas.
[8] P. Delmas,et al. The short-term effects of conjugated estrogen on bone turnover in older women. , 1994, The Journal of clinical endocrinology and metabolism.
[9] P. Mäenpää,et al. Steroid hormone modulation of vitamin D receptor levels in human MG-63 osteosarcoma cells. , 1994, Biochemical and biophysical research communications.
[10] S. Wimalawansa. Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: four-year randomized study. , 1995, The American journal of medicine.
[11] P. Blockx,et al. Immunoradiometric method and electrophoretic system compared for quantifying bone alkaline phosphatase in serum. , 1995, Clinical chemistry.
[12] E. Cicinelli,et al. Bone metabolism changes after transdermal estradiol dose reduction during estrogen replacement therapy: a 1-year prospective study. , 1994, Maturitas.
[13] K. Savolainen,et al. Two‐site enzyme immunoassay for measuring intact human osteocalcin in serum , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[14] G. Stein,et al. Relationship of cell growth to the regulation of tissue‐specific gene expression during osteoblast differentiation , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] S. Schwartz,et al. Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. , 1996, The Journal of clinical endocrinology and metabolism.
[16] C. Christiansen,et al. Plasma BGP: an indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women , 1988, European journal of clinical investigation.
[17] T. Spector,et al. Markers of bone metabolism in postmenopausal women with rheumatoid arthritis. Effects of corticosteroids and hormone replacement therapy. , 1995, Arthritis and rheumatism.
[18] K. Kushida,et al. Comparison of markers for bone formation and resorption in premenopausal and postmenopausal subjects, and osteoporosis patients. , 1995, The Journal of clinical endocrinology and metabolism.
[19] P. Qvist,et al. A simple enzyme-linked immunosorbent assay of human osteocalcin. , 1994, Clinical chemistry.
[20] L. Mosekilde,et al. Serum markers of type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometry , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[21] K. Savolainen,et al. An improved method for routine determination of vitamin D and its hydroxylated metabolites in serum from children and adults. , 1981, Clinica chimica acta; international journal of clinical chemistry.
[22] L. Mosekilde,et al. Effects of a combined estrogen‐gestagen regimen on serum levels of the carboxy‐terminal propeptide of human type I procollagen in osteoporosis , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[23] P. Delmas,et al. Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[24] C. de la Piedra,et al. Lack of correlation between levels of osteocalcin and bone alkaline phosphatase in healthy control and postmenopausal osteoporotic women. , 1995, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[25] S. Saarikoski,et al. Does vitamin D3 have negative effects on serum levels of lipids? A follow-up study with a sequential combination of estradiol valerate and cyproterone acetate and/or vitamin D3. , 1995, Maturitas.
[26] M. Parviainen,et al. Alkaline phosphatase isoenzymes in serum determined by high-performance anion-exchange liquid chromatography with detection by enzyme reaction. , 1988, Clinical Chemistry.
[27] A. Struyvenberg,et al. BLOOD-LIPIDS IN RENAL DISEASE , 1975, The Lancet.
[28] A. Ratcliffe,et al. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[29] D. Ciocca,et al. Estrogen receptors in human nontarget tissues: biological and clinical implications. , 1995, Endocrine reviews.
[30] K. Mann,et al. Concurrent assays of circulating bone Gla-protein and bone alkaline phosphatase: effects of sex, age, and metabolic bone disease. , 1988, The Journal of clinical endocrinology and metabolism.
[31] Harry K. Genant,et al. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. , 1993, The American journal of medicine.
[32] R. Prince. Counterpoint: estrogen effects on calcitropic hormones and calcium homeostasis. , 1994, Endocrine reviews.
[33] R. Honkanen,et al. Osteoporosis risk factors, gynaecological history and fractures in perimenopausal women--the results of the baseline postal enquiry of the Kuopio Osteoporosis Risk Factor and Prevention Study. , 1993, Maturitas.